Pakistan vs Sur: The number of people with susceptibility test result for rifampicin
Pakistan
125,823
in 2021
Sur
67
in 2021
Pakistan rank
4th
Sur rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Pakistan
- Sur
How they compare
Pakistan currently reports 125,823 against 67 in Sur, a difference of 125,756.
That makes Pakistan's figure about 1,878.0 times Sur's.
Across all 5 years both countries report, Pakistan has been ahead every year.
Pakistan ranks 4th and Sur ranks 2nd of 155 countries.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Pakistan | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55,256 | 81.33 | 55,175 | Pakistan |
| 2020s | 99,270 | 66.5 | 99,204 | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Pakistan or Sur?
- Pakistan, at 125,823 against 67 in Sur as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Pakistan and Sur?
- 125,756, with Pakistan ahead.
- How many years of comparable data are there for Pakistan and Sur?
- 5 years are reported by both, from 2017 to 2021.
- How do Pakistan and Sur rank globally for the number of people with susceptibility test result for rifampicin?
- Pakistan ranks 4th and Sur ranks 2nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.